首页> 外文期刊>Molecular diagnosis & therapy >Clinical Evaluation of IntelliPlex (TM) KRAS G12/13 Mutation Kit for Detection of KRAS Mutations in Codon 12 and 13: A Novel Multiplex Approach
【24h】

Clinical Evaluation of IntelliPlex (TM) KRAS G12/13 Mutation Kit for Detection of KRAS Mutations in Codon 12 and 13: A Novel Multiplex Approach

机译:用于检测密码子12和13中KRAS突变检测的智能化(TM)KRAS G13突变试剂盒的临床评价:一种新型多重方法

获取原文
获取原文并翻译 | 示例
       

摘要

Background Colorectal cancer (CRC) is among the most frequently occurring cancers worldwide and its incidence is forecasted to increase. Testing for KRAS (Kirsten rat sarcoma viral oncogene homolog) mutations in colorectal tissue biopsy samples has become a crucial tool to guide therapeutic decisions for personalized treatment.
机译:背景,结直肠癌(CRC)是全球最常见的癌症之一,其发病率预测增加。 结直肠组织活检样品中的KRAs(Kirsten大鼠肉瘤病毒癌症同源物)突变已成为指导个性化治疗的治疗决策的重要工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号